T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECHO
651
EchoStar
ECHO
$25.5B
| $81.2M | 0.01% |
693,229
+555,360
| +403% | +$63.7M |
|
652
AppFolio
APPF
$5.85B
| $81M | 0.01% |
513,441
-155,876
| -23% | -$29.5M |
|
653
First Bancorp
FBP
$4.4B
| $81M | 0.01% |
3,793,371
+134,222
| +4% | +$2.89M |
|
654
TPG
TPG
$6.87B
| $80.8M | 0.01% |
1,993,534
-1,565,011
| -44% | -$80.3M |
|
655
Spyre Therapeutics
SYRE
$8.87B
| $80.6M | 0.01% |
1,598,730
-3,152
| -0.2% | -$119K |
|
656
Realty Income
O
$61.2B
| $79.8M | 0.01% |
1,303,888
-26,791
| -2% | -$1.68M |
|
657
Affirm
AFRM
$23.5B
| $78.9M | 0.01% |
1,722,380
+24,880
| +1% | +$1.44M |
|
658
Patrick Industries
PATK
$2.8B
| $78.9M | 0.01% |
709,989
-38,915
| -5% | -$4.81M |
|
|
CAI
659
Caris Life Sciences
CAI
$4.39B
| $78.2M | 0.01% |
4,371,771
-456,194
| -9% | -$9.97M |
|
660
Camden Property Trust
CPT
$11.3B
| $77.8M | 0.01% |
796,506
+4,520
| +0.6% | +$479K |
|
661
Kodiak Sciences
KOD
$2.59B
| $77.7M | 0.01% |
2,039,350
+869,171
| +74% | +$22.5M |
|
662
Sanofi
SNY
$104B
| $77.7M | 0.01% |
1,613,375
-1,260,284
| -44% | -$58.8M |
|
663
SharkNinja
SN
$21B
| $77.4M | 0.01% |
731,101
+421,641
| +136% | +$49.3M |
|
664
Xenon Pharmaceuticals
XENE
$6.32B
| $77.3M | 0.01% |
1,329,591
+467,291
| +54% | +$21.5M |
|
|
ABVX
665
Abivax
ABVX
$11B
| $77M | 0.01% |
691,670
+40,026
| +6% | +$4.74M |
|
666
Ferguson
FERG
$44.7B
| $77M | 0.01% |
330,136
+35,082
| +12% | +$8.54M |
|
667
Flex
FLEX
$43.4B
| $76.7M | 0.01% |
1,171,913
+299,293
| +34% | +$19.1M |
|
668
Exelon
EXC
$48.6B
| $76.7M | 0.01% |
1,564,263
-99,459
| -6% | -$4.63M |
|
669
Elanco Animal Health
ELAN
$12.4B
| $76.6M | 0.01% |
3,201,490
+404,737
| +14% | +$9.89M |
|
670
Casey's General Stores
CASY
$31.9B
| $76.3M | 0.01% |
104,794
-10,486
| -9% | -$6.83M |
|
|
FIGR
671
Figure Technology Solutions
FIGR
$6.1B
| $75.9M | 0.01% |
2,234,183
+2,218,244
| +13,917% | +$95.6M |
|
672
Skyward Specialty Insurance
SKWD
$2.45B
| $75.8M | 0.01% |
1,735,098
+551,178
| +47% | +$25M |
|
673
BILL Holdings
BILL
$4.33B
| $75.8M | 0.01% |
1,978,694
-952,109
| -32% | -$42.6M |
|
674
Mercury Systems
MRCY
$6.2B
| $75M | 0.01% |
1,028,609
+160,939
| +19% | +$14M |
|
675
Arm
ARM
$278B
| $74.7M | 0.01% |
493,865
+16,825
| +4% | +$2.04M |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.